Since the beginning of the Italian program of immunization against hepatitis B, vaccine has been given to more than 9 million children, with an outstanding record of safety and efficacy. The coverage rate is globally around 94%, with differences between Northern and Southern regions, the latter having the lower acceptance rate. According to the National Surveillance System (SEIEVA), the incidence of acute hepatitis B per10(5) inhabitants declined from 5.4 in 1990 to 2.9 in 1998. The reduction was even greater among 15-24-year-old individuals, where the incidence rate per 10(5) decreased from 17.3 to 4.2 in the same period. In parallel with the decline of hepatitis B, Delta hepatitis has also dropped significantly. We expect that by the year...
The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing patter...
From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southe...
The morbidity and mortality rates of viral hepatitis A, B and Delta have dramatically dropped in Ita...
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at hi...
Viral hepatitis B is a vaccine-preventable disease. Vaccination has proved to be safe and highly eff...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
BACKGROUND: In Italy routine infant and adolescent immunization against hepatitis B was introduced i...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
In Italy, as in most industrialized countries, the burden of hepatitis B has progressively declined ...
Background: In 1991, a mass immunization campaign against the hepatitis B virus (HBV) for children a...
Abstract Background Hepatitis B (HBV) infection is an important cause of morbidity and mortality and...
Background and Aim: The universal hepatitis B vaccination for infants and 12-year-old adolescents (t...
Background: Viral hepatitis caused by hepatitis B virus (HBV) is a leading cause of acute and chroni...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing patter...
From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southe...
The morbidity and mortality rates of viral hepatitis A, B and Delta have dramatically dropped in Ita...
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at hi...
Viral hepatitis B is a vaccine-preventable disease. Vaccination has proved to be safe and highly eff...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
BACKGROUND: In Italy routine infant and adolescent immunization against hepatitis B was introduced i...
Viral hepatitis B, which is a major health problem worldwide, is endemic in Italy. In response to th...
In Italy, as in most industrialized countries, the burden of hepatitis B has progressively declined ...
Background: In 1991, a mass immunization campaign against the hepatitis B virus (HBV) for children a...
Abstract Background Hepatitis B (HBV) infection is an important cause of morbidity and mortality and...
Background and Aim: The universal hepatitis B vaccination for infants and 12-year-old adolescents (t...
Background: Viral hepatitis caused by hepatitis B virus (HBV) is a leading cause of acute and chroni...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing patter...
From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southe...
The morbidity and mortality rates of viral hepatitis A, B and Delta have dramatically dropped in Ita...